Replies to post #1015 on Nexien BioPharma Inc (NXEN)

[Traderfan]

That's exactly what I said an hour ago. 3 is possible but certain financial metrics need to fit.

[Renegades17]

Minimum pre split stock price

So the bare minimum stock price to uplist is $2 assuming other requirements are met. That equates to a $0.33/share pre reverse split price. That should be the floor. Realistically speaking, if they want to raise additional capital and attract institutional investors, they need the stock price to be above $5 (usually well above..how many IPOs have you seen done at $5?).

Regarding the $200mm in net asset comment (again that's market value, not book value, which is what determines the stock price), if you think they don't have that, where do you disagree with the analysis posted in the sticky notes section? Keep in mind that analysis excluded the potential value from the cannabis-based drug that they are pursuing. If you take the mid point of that valuation ($330mm), the stock price pre-split should be over $1.

The dilution was tough to take, and I think poorly timed and naive on their part, but those selling below $0.20 yesterday will regret it IMO. I think the stock should be selling at $0.50-$0.80 at a minimum, but we might have to wait until they file financials and disclose more information on their assets.